Anal Reprieve

Just for fun. I noticed tonite a portfolio holding, GIVN, announced something to be construed as negative on their path to greater internal diagnostics. This is a profitable company with a proprietary and leadership position in a minimally invasive and necessary diagnostic field. The stock is already significantly umdervalued IMHO. If it prints down tomorrow I am a buyer. Please do your own due diligence but I regard this as a significant buying opportunity. regards. shb